Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Glaxosmithkline (GSK) Share News

UK Earnings, Trading Statements Calendar - Week Ahead

5th Feb 2014 06:29

MARKET COMMENT: FTSE 100 Closes Lower For Fifth Straight Day

4th Feb 2014 17:39

LONDON (Alliance News) - The FTSE 100 closed lower for a fifth consecutive day Tuesday, even though the index was higher at one point, as concerns about the impact of the Federal Reserve's tapering of its economic stimulus programme continued to weigh on stock markets across the world. <b Read More

EARNINGS PREVIEW: AstraZeneca Set To Swing To Loss, Glaxo Flatlines

4th Feb 2014 16:27

LONDON (Alliance News) - The UK's two largest pharmaceuticals companies will report 2013 earnings this week, with AstraZeneca expected to show a fourth quarter loss when it reports Thursday, while GlaxoSmithKline profits are expected to have flatlined over the year as a whole. Both companie Read More

UK Earnings, Trading Statements Calendar - Week Ahead

4th Feb 2014 16:06

UK Earnings, Trading Statements Calendar - Week Ahead

4th Feb 2014 06:11

DIRECTOR DEALINGS: Glaxo Executive Diretor Alloctaed ADSs

3rd Feb 2014 16:21

LONDON (Alliance News) - LONDON (Alliance News) - Healthcare and pharmaceuticals giant GlaxoSmithKline PLC Monday said Executive Director Moncef Slaoui was allocated 17 American Depositary Shares at a price of USD51.54 each Friday. Glaxo shares were up 0.8% at 1,576.50 pence Monday. B Read More

UK Earnings, Trading Statements Calendar - Week Ahead

3rd Feb 2014 16:19

UK MIDDAY BRIEFING: Mis-Selling Bill Continues To Mount For UK Banks

3rd Feb 2014 13:46

LONDON (Alliance News) - UK banks are still counting the cost of their product mis-selling, with Lloyds Banking Group Monday adding a further GBP1.93 billion to the amount it has set aside to cover claims for previous sales of payment protection insurance and interest rate hedging products. <p Read More

UK WINNERS & LOSERS: Rurelec Drops 25% As Bolivia Award Disappoints

3rd Feb 2014 11:26

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday. ------- FTSE 100 - WINNERS Randgold Resources, up 2.1%. In a difficult environment for gold miners, Read More

REPEAT: Glaxo Gets FDA Breakthrough Therapy Label For Bone Marrow Treatment

3rd Feb 2014 11:00

LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it had received Breakthrough Therapy designation for its bone marrow disorder treatment Promacta/Revolade from the US Food and Drug Administration. The treatment is designed for patients with severe aplastic anemia, a rare disord Read More

Glaxo Gets FDA Breakthrough Therapy Label For Bone Marrow Treatment

3rd Feb 2014 10:46

PRESS: Glaxo To Announce Late Stage Trials On 10 New Drugs - The Telegraph

3rd Feb 2014 07:54

LONDON (Alliance News) - GlaxoSmithKline PLC will this week announce plans to launch late stage clinical trials on ten new drugs over the next two years, the Daily Telegraph reported Monday, without saying where it got the information. The list will include medicines in Glaxo?s key areas of Read More

UK Earnings, Trading Statements Calendar - Week Ahead

31st Jan 2014 16:07

Sinclair IS Pharma Acquires Wrinkle Treatment Atlean From Glaxo

31st Jan 2014 09:00

LONDON (Alliance News) - Sinclair IS Pharma PLC said Friday that it had acquired dermal filler Atlean from GlaxoSmithKline PLC's dermatology business Stiefel. The company said that Atlean, used to reduce wrinkles, will complement its existing facial care brands Sculptra and Perfectha. Atlea Read More

UK Earnings, Trading Statements Calendar - Week Ahead

31st Jan 2014 06:26

UK Earnings, Trading Statements Calendar - Week Ahead

30th Jan 2014 16:13

UK Earnings, Trading Statements Calendar - Week Ahead

30th Jan 2014 06:29

UK Earnings, Trading Statements Calendar - Week Ahead

29th Jan 2014 16:33

Glaxo Tafinlar-Mekinist Combo Treatment Study Meets Primary Endpoint

24th Jan 2014 13:00

LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that its Phase III study of the combination treatment of Tafinlar and Mekinist for the treatment of metastatic melenoma had reached its primary endpoint. The company said the response rate and interim overall survival results in the s Read More

UK MIDDAY BRIEFING: Bank Of England Now Focused On Productivity

24th Jan 2014 12:41

LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process. In a speech at the World Ec Read More

FTSE 100 Latest

Value10,472.11

Change118.27